Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
Corner Therapeutics Address
Watertown, MA United States
Corner Therapeutics Email
Past Companies
Corner TherapeuticsScientist|Immuno-Oncology
Scholar RockProtein Expression|Cell Line Engineering Scientist
Claritas GenomicsScientist II- Research and Development